Gene Silencing Market

The gene silencing market involves technologies like RNAi and CRISPR-Cas9 to inhibit gene expression for therapeutic and research purposes. The primary customers are pharmaceutical and biotechnology companies, which use these tools for drug discovery and developing novel therapies. Key growth drivers include a deeper understanding of the genetic basis of diseases, the rising prevalence of genetic and chronic disorders, and significant advancements in gene silencing technologies and their delivery systems.